logo

For the Inventor, By the Inventor

Kawasaki, Japan

Saiko Hosokawa

This inventor holds 9 USPTO granted patents. Top assignees: Mitsubishi Chemical Corporation, Mitsubishi Kasei Corporation. Active years: 1993-2006.

USPTO Granted Patents = 9

% Patents Active = 77.8

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 168(Granted Patents)


Location History:

  • Kawasaki, JP (1993 - 2000)
  • Kawaski, JP (2004)
  • Kanagawa, JP (2002 - 2006)

Company Filing History:

goldMedal7 out of 2,422 
 
Mitsubishi Chemical Corporation
 patents
silverMedal2 out of 499 
 
Mitsubishi Kasei Corporation
 patents

Years Active: 1993-2006

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7048944 - Method for preparing closed vesicles (2006-05-23),
2. 6787153 - Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane (2004-09-07),
3. 6475517 - Method for preparing closed vesicles (2002-11-05),
4. 6139869 - Human monoclonal antibody specifically binding to surface antigen of (2000-10-31),
5. 5990297 - Human monoclonal antibody specifically binding to surface antigen of (1999-11-23),
6. 5990287 - Human monoclonal antibody specifically binding to surface antigen of (1999-11-23),
7. 5837845 - Human monoclonal antibody specifically binding to surface antigen of (1998-11-17),
8. 5767246 - Human monoclonal antibody specifically binding to surface antigen of (1998-06-16),
9. 5264221 - Drug-containing protein-bonded liposome (1993-11-23),

Title: Saiko Hosokawa: Innovator in Pharmaceutical Technologies

Introduction

Saiko Hosokawa is a prominent inventor based in Kawasaki, Japan, known for her significant contributions to pharmaceutical technologies. With a total of nine patents to her name, she has made remarkable advancements in the field of drug delivery systems and cancer treatment.

Latest Patents

One of her latest patents is a method for preparing closed vesicles. This innovative method involves rehydrating a closed vesicle using a specific rehydration solution. The closed vesicle comprises dehydrated micelle particles or dehydrated amphipathic micelle bilayers, preferably a liposome that loads a pharmaceutically active substance. The method is characterized by conducting the rehydration at low temperatures, ranging from 0°C to 10°C. This technique provides a rehydrated stable vesicle without leaking the loaded substance. Another notable patent is for a human monoclonal antibody that specifically binds to a surface antigen of cancer cell membranes. This invention includes an isolated DNA encoding the antibody and a hybridoma that produces the antibody. Additionally, it provides an anti-cancer formulation that comprises the monoclonal antibody bonded to the surface of a liposome enclosing an anti-cancer agent or toxin.

Career Highlights

Throughout her career, Saiko Hosokawa has worked with leading companies in the industry, including Mitsubishi Chemical Corporation and Mitsubishi Kasei Corporation. Her work has significantly impacted the development of innovative pharmaceutical solutions.

Collaborations

Saiko has collaborated with notable professionals in her field, including Toshiaki Tagawa and Kazuhiro Nagaike. These collaborations have further enhanced her research and development efforts.

Conclusion

Saiko Hosokawa's contributions to pharmaceutical technologies through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in drug delivery and cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…